advertisement
3.8 Pharmacology (12)
Showing records 1 to 12
Display all abstracts in classification 3.8 Pharmacology
Search within classification 3.8 Pharmacology53533 Synthesis and biological evaluation of urea derivatives as highly potent and selective rho kinase inhibitors
Yin Y; Lin L; Ruiz C; Khan S; Cameron MD; Grant W; Pocas J; Eid N; Park H; Schröter T; Lograsso PV; Feng Y
Journal of Medicinal Chemistry 2013; 56: 3568-3581
53575 Acetylcholinesterase inhibition promotes retinal vasoprotection and increases ocular blood flow in experimental glaucoma
Almasieh M; MacIntyre JN; Pouliot M; Casanova C; Vaucher E; Kelly ME; Di Polo A
Investigative Ophthalmology and Visual Science 2013; 54: 3171-3183
53775 Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases
Vadlapatla RK; Vadlapudi AD; Mitra AK
Current Drug Targets 2013; 14: 919-935
53708 Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio
Kernt M; Arend N; Buerger A; Mann T; Haritoglou C; Ulbig MW; Kampik A; Hirneiss C
Journal of Glaucoma 2013; 22: 404-412
53856 An Effective Prodrug Strategy to Selectively Enhance Ocular Exposure of a Cannabinoid Receptor (CB1/2) Agonist
Mainolfi N; Powers J; Amin J; Long D; Lee W; McLaughlin ME; Jaffee B; Brain CT; Elliott J; Sivak JM
Journal of Medicinal Chemistry 2013; 0:
53523 Targeting the A3 adenosine receptor for glaucoma treatment (review)
Fishman P; Cohen S; Bar-Yehuda S
Molecular medicine reports 2013; 7: 1723-1725
53738 Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate
Santos-Carvalho A; Elvas F; Alvaro AR; Ambrósio AF; Cavadas C
Cell Death and Disease 2013; 4: e636
53686 Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity
Bai N; Hayashi H; Aida T; Namekata K; Harada T; Mishina M; Tanaka K
Molecular brain 2013; 6: 22
53695 Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo
Carta F; Akdemir A; Scozzafava A; Masini E; Supuran CT
Journal of Medicinal Chemistry 2013; 56: 4691-4700
53778 Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2
Foureaux G; Nogueira JC; Nogueira BS; Fulgêncio GO; Menezes GB; Fernandes SO; Cardoso VN; Fernandes RS; Oliveira GP; Franca JR; Faraco AA; Raizada MK; Ferreira AJ
Investigative Ophthalmology and Visual Science 2013; 54: 4296-4306
53559 Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma
Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
Journal of Pharmacology and Experimental Therapeutics 2013; 346: 138-145
53742 VEGF induces TGF-β1 expression and myofibroblast transformation after glaucoma surgery
Park HY; Kim JH; Park CK
American Journal of Pathology 2013; 182: 2147-2154
